Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
Our drug discovery model has identified two novel STAT3 SH2 domain inhibitors 323-1 and 323-2 (delavatine A stereoisomers) in a series of experiments. In silico computational modeling, drug affinity responsive target stability (DARTS), and fluorescence polarization (FP) assays altogether determined...
Saved in:
Main Authors: | Yaping Hua (Author), Xing Yuan (Author), Yun-heng Shen (Author), Jinxin Wang (Author), Waqas Azeem (Author), Shuo Yang (Author), Alexandra Gade (Author), Seyed Mohammad Lellahi (Author), Anne Margrete Øyan (Author), Xisong Ke (Author), Wei-dong Zhang (Author), Karl-Henning Kalland (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain
by: Elena Gabriele, et al.
Published: (2017) -
Targeting STAT3 and STAT5 in Cancer
Published: (2020) -
The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
by: Rhiannon Morris, et al.
Published: (2021) -
Prevention of STAT3-related pathway in SK-N-SH cells by natural product astaxanthin
by: Shao-Qian Sun, et al.
Published: (2023) -
Acitretin modulates HaCaT cells proliferation through STAT1- and STAT3-dependent signaling
by: Xuan Qin, et al.
Published: (2017)